Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guanze Medical Information Industry (Holding) Co has a current ratio of 5.61. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
HKSE:02427's Current Ratio is ranked better than 88.68% of 212
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.11
vs HKSE:02427: 5.61
Guanze Medical Information Industry (Holding) Co (HKSE:02427) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Guanze Medical Information Industry (Holding) Co Current Ratio Related Terms
Guanze Medical Information Industry (Holding) Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guanze Medical Information Industry (Holding) Co Current Ratio Chart
Guanze Medical Information Industry (Holding) Co Annual Data
HKSE:02427 vs TMO, DHR, IDXX: Current Ratio Comparison
For the Diagnostics & Research subindustry, Guanze Medical Information Industry (Holding) Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guanze Medical Information Industry (Holding) Co Current Ratio vs Medical Diagnostics & Research Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guanze Medical Information Industry (Holding) Co (HKSE:02427) has a Current Ratio of 5.61 as of Dec. 2025. This is 28% above median its historical median of 4.38. Over the past decade, Guanze Medical Information Industry (Holding) Co's Current Ratio has ranged from 1.95 to 6.51. According to the industry distribution chart, Guanze Medical Information Industry (Holding) Co ranks #24 out of 212 companies in the Medical Diagnostics & Research industry, placing it in the top 11.3%.
Is Guanze Medical Information Industry (Holding) Co's Current Ratio too high?
Guanze Medical Information Industry (Holding) Co's current Current Ratio of 5.61 is 28% above median its 10-year median of 4.38. Over the past 10 years, this metric has ranged from a low of 1.95 to a high of 6.51. The Medical Diagnostics & Research industry median Current Ratio is 2.11. Guanze Medical Information Industry (Holding) Co's value of 5.61 is 165.9% above this industry median. Based on the distribution chart, Guanze Medical Information Industry (Holding) Co ranks #24 out of 212 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Guanze Medical Information Industry (Holding) Co has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guanze Medical Information Industry (Holding) Co's Current Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Guanze Medical Information Industry (Holding) Co ranks #24 out of 212 companies for Current Ratio. This places Guanze Medical Information Industry (Holding) Co in the top 11% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.11. Guanze Medical Information Industry (Holding) Co's value of 5.61 is 165.9% above this benchmark. Historically, Guanze Medical Information Industry (Holding) Co's own Current Ratio has ranged from 1.95 to 6.51 over the past decade. While the company's 10-year median is 4.38 vs. the industry median of 2.11, Guanze Medical Information Industry (Holding) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Diagnostics & Research company?
The median Current Ratio among Medical Diagnostics & Research companies is 2.11, based on 212 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guanze Medical Information Industry (Holding) Co's current Current Ratio of 5.61 is 165.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median Current Ratio is 2.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guanze Medical Information Industry (Holding) Co's current Current Ratio is 5.61, which is 28% above median its own 10-year median of 4.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guanze Medical Information Industry (Holding) Co stock overvalued right now?
Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co (HKSE:02427) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.28, compared to a current price of HK$2.80 — trading 900% above its estimated fair value. The current Current Ratio is 5.61, which is 28% above median its 10-year median of 4.38 and 165.9% above the Medical Diagnostics & Research industry median of 2.11. Guanze Medical Information Industry (Holding) Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Guanze Medical Information Industry (Holding) Co (HKSE:02427), the current Current Ratio is 5.61 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guanze Medical Information Industry (Holding) Co (HKSE:02427) Overvalued in 2026?
Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co stock appears to be overvalued.
The current stock price of HK$2.80 is trading 900% above its estimated GF Value™ of HK$0.28.
GuruFocus considers Guanze Medical Information Industry (Holding) Co to be Significantly Overvalued.
Key valuation signals for HKSE:02427:
Current Ratio: 5.61 (28% above median its 10-year median of 4.38)
GF Value™: HK$0.28 vs. price of HK$2.80 (900% above fair value)
Industry Position: 165.9% above the Medical Diagnostics & Research median (#24 of 212)
No single metric tells the full story. See the HKSE:02427 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guanze Medical Information Industry (Holding) Co Business Description
Guanze Medical Information Industry (Holding) Co Ltd is a medical imaging solutions provider, principally engaged in providing medical imaging film products and medical imaging cloud services in Shandong Province. The company generates the majority of its revenue from the PRC.
52GF Score
Get the complete analysis for HKSE:02427
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02427 has been successfully added to your 
